Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study

Vaccine

Volumn 34, Issue 1, 2016, Pages 142-150

  Maertens, Kirsten ^a   Caboré, Raïssa Nadège ^b   Huygen, Kris ^b   Hens, Niel ^c   Van Damme, Pierre ^a   Leuridan, Elke ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^c HASSELT UNIVERSITY   (Belgium)

Author keywords

Blunting; Maternal antibodies; Pertussis; Vaccination in pregnancy

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; MATERNAL ANTIBODY; BACTERIUM ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BELGIUM; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FEVER; FEBRILE CONVULSION; FEMALE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; IMMUNE RESPONSE; INFANT; INJECTION SITE REACTION; LIMB SWELLING; MALE; OLIGOHYDRAMNIOS; PERTUSSIS; PLACENTA PREVIA; PLACENTAL TRANSFER; PNEUMONIA; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; THRUSH; VACCINATION; VOMITING; BLOOD; DISEASE TRANSMISSION; IMMUNIZATION; NEWBORN; PASSIVE IMMUNIZATION; PREVENTION AND CONTROL; TREATMENT OUTCOME; WHOOPING COUGH;

ADULT; ANTIBODIES, BACTERIAL; BELGIUM; COHORT STUDIES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WHOOPING COUGH;

EID: 84949665210     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.10.100     Document Type: Article

References (43)

1. WHO Immunization, vaccines and biologicals: pertussis 2014, Available from 〈http://www.who.int/wer/2015/wer9035.pdf?ua=1〉 (accessed on 18/10/2015).
2. Pebody R.G., Gay N.J., Giammanco A., Baron S., Schellekens J., Tischer A., et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005, 133(Feb (1)):159-171.
3. Crowcroft N.S., Pebody R.G. Recent developments in pertussis. Lancet 2006, 367(Jun (9526)):1926-1936.
4. Crowcroft N.S., Stein C., Duclos P., Birmingham M. How best to estimate the global burden of pertussis?. Lancet Infect Dis 2003, 3(7):413-418.
5. Hoge Gezondheidsraad Pertussis, vaccination 2013, Hoge Gezondheidsraad, België, Available from 〈https://www.zorg-en-gezondheid.be/uploadedFiles/NLsite_v2/Ziekten/Vaccinaties/Informatie_voor_vaccinatoren/vaccinatie_fiche_volw_kinkhoest_20130830.pdf〉 (accessed on: 18/10/2015).
6. Braeye T., De Schrijver K., Pierard D., Huygen K. Infectieziekten bij kinderen, die voorkomen kunnen worden door vaccinatie. Kinkhoest. Jaarrapport 2013 2013, Available from 〈http://www.wiv-isp.be/SiteCollectionDocuments/Infectieziekten%20bij%20kinderen,%20die%20voorkomen%20kunnen%20worden%20door%20vaccinatie.%20Jaarrapport%202013.pdf〉 (accessed on: 18/10/2015).
7. Van Savage J., Decker M.D., Edwards K.M., Sell S.H., Karzon D.T. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 1990, 161(3):487-492.
8. Edwards K.M. Pertussis: an important target for maternal immunization. Vaccine 2003, 21(Jul (24)):3483-3486.
9. Malek A., Sager R., Schneider H. Maternal-fetal transport of immunoglobulin-G and its subclasses during the 3Rd trimester of human-pregnancy. Am J Reprod Immunol 1994, 32(1):8-14.
10. Clark T.A. Changing pertussis epidemiology: everything old is new again. J Infect Dis 2014, 209(Apr (7)):978-981.
11. De Schutter S., Maertens K., Baerts L., De Meester I., Van Damme P., Leuridan E. Quantification of vaccine-induced antipertussis toxin secretory IgA antibodies in breast milk: comparison of different vaccination strategies in women. Pediatr Infect Dis J 2015, 34(6):e149-e152.
12. Lindsey B., Kampmann B., Jones C. Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis 2013, 26(Jun (3)):248-253.
13. Leuridan E., Hens N., Hutse V., Aerts M., Van Damme P. Kinetics of maternal antibodies against rubella and varicella in infants. Vaccine 2011, 29(Jun (11)):2222-2226.
14. Gall S.A., Myers J., Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011, 204(4). 334.e1-335.e1.
15. Hardy-Fairbanks A.J., Pan S.J., Decker M.D., Johnson D.R., Greenberg D.P., Kirkland K.B., et al. Immune responses in infants whose mothers received Tdap vaccine during pregnancy. Pediatr Infect Dis J 2013, 32(11):1257-1260.
16. Munoz F.M., Bond N.H., Maccato M., Pinell P., Hammill H.A., Swamy G.K., et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014, 311(May (17)):1760-1769.
17. Vilajeliu A., Gonce A., Lopez M., Costa J., Rocamora L., Rios J., et al. Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn. Vaccine 2015, 33(Feb (8)):1056-1062.
18. Abu Raya B., Srugo I., Kessel A., Peterman M., Bader D., Gonen R., et al. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels-a prospective study. Vaccine 2014, 32(Oct (44)):5787-5793.
19. Van der Zee A., Schellekens J.F., Mooi F.R. Laboratory Diagnosis of Pertussis. Clin Microbiol Rev. 2015, 28:1005-1026.
20. Plotkin S.A. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010, 17(7):1055-1065.
21. Leuridan E., Hens N., Peeters N., de Witte L., Van der Meeren O., Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011, 30(Jan (7)):608-610.
22. Neter J., Kutner M., Nachtsheim C., Wasserman W. Applied linear statistical models 1996, Irwin, Chicago, IL. 4th ed.
23. Agresti A. Categorical data analysis 2002, Wiley, New York, NY. 2nd ed.
24. Little R., Rubin D. Statistical analysis with missing data 1987, Wiley, Hoboken, New Jersey.
25. Breiman L. Random forests. Machine learn 2001, vol. 45, 1:5-32.
26. Theeten H., Hens N., Vandermeulen C., Depoorter A.M., Roelants M., Aerts M., et al. Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey. Vaccine 2007, 25(Jun (26)):4940-4948.
27. Donegan K., King B., Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014, 349. (g4219, (Clinical research ed)).
28. GlaxoSmithKline, Inc., Product monograph, Boostrix. 2013, Available from (). http://www.gsk.ca/english/docs-pdf/product-monographs/Boostrix.pdf.
29. Jacquemyn Y., Osmanovic F., Martens G. Preeclampsia and birthweight by gestational age in singleton pregnancies in Flanders, Belgium: a prospective study. Clin Exp Obstet Gynecol 2006, 33(2):96-98.
30. de Voer R.M., van der Klis F.R., Nooitgedagt J.E., Versteegh F.G., van Huisseling J.C., van Rooijen D.M., et al. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis. Clin Infect Dis 2009, 49(Jul (1)):58-64.
31. Healy C.M., Rench M.A., Baker C.J. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013, 56(Feb (4)):539-544.
32. Huygen K., Cabore R.N., Maertens K., Van Damme P., Leuridan E. Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women. Vaccine 2015, 33:4117-4123.
33. Mooi F.R., de Greeff S.C. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007, 7(9):614-624.
34. Heininger U., Riffelmann M., Bar G., Rudin C., von Konig C.H. The protective role of maternally derived antibodies against Bordetella pertussis in young infants. Pediatr Infect Dis J 2013, 32(6):695-698.
35. Englund J.A., Anderson E.L., Reed G.F., Decker M.D., Edwards K.M., Pichichero M.E., et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995, 96(Sep (3 Pt 2)):580-584.
36. Sako W.T.W., Witt D.B., et al. Early immunization against pertussis with alum precipitated vaccine. JAMA 1945, 127:379-383. (the journal of the American Medical Association).
37. Glezen W.P. Effect of maternal antibodies on the infant immune response 3. Vaccine 2003, 21(24):3389-3392.
38. Provenzano R.W.W.L., Sullivan C.L. Immunization and antibody response in the newborn infant. N Engl J Med 1965, 273:959-965.
39. Saffar M.J., Ajami A., Khalilian A.R., Qaheri A., Saffar H. Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination. Indian Pediatr 2007, 44(12):916-918.
40. Van Rie A., Wendelboe A.M., Englund J.A. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J 2005, 24(5 Suppl):S62-S65.
41. Jones C., Pollock L., Barnett S.M., Battersby A., Kampmann B. The relationship between concentration of specific antibody at birth and subsequent response to primary immunization. Vaccine 2014, 32(Feb (8)):996-1002.
42. Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol 2014, 5:446.
43. Frew P.M., Saint-Victor D.S., Isaacs M.B., Kim S., Swamy G.K., Sheffield J.S., et al. Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices. Clin Infect Dis 2014, 59(Dec (Suppl 7)):S400-S407. (an official publication of the Infectious Diseases Society of America).